ROYAL BANK OF CANADA - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 16 filers reported holding LEAP THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$0230.0%0.00%
Q4 2022$023
-88.9%
0.00%
Q3 2022$0
-100.0%
208
-79.2%
0.00%
Q2 2022$1,000
-50.0%
1,000
-0.6%
0.00%
Q1 2022$2,000
-33.3%
1,006
-50.2%
0.00%
Q2 2021$3,000
-25.0%
2,019
+0.1%
0.00%
Q1 2021$4,0002,016
+12500.0%
0.00%
Q4 2020$0
-100.0%
16
-96.7%
0.00%
Q3 2020$1,0000.0%492
+28.1%
0.00%
Q2 2020$1,0000.0%3840.0%0.00%
Q1 2020$1,000384
+10.0%
0.00%
Q3 2019$0349
+2584.6%
0.00%
Q2 2019$0130.0%0.00%
Q1 2019$0130.0%0.00%
Q4 2018$0130.0%0.00%
Q3 2018$0
-100.0%
13
-90.4%
0.00%
Q4 2017$1,0001360.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
M28 Capital Management LP 1,000,000$3,240,0002.53%
Ally Bridge Group (NY) LLC 1,815,000$5,881,0002.06%
TANG CAPITAL MANAGEMENT LLC 2,500,000$8,100,0001.63%
Ghost Tree Capital, LLC 1,350,000$4,374,0001.57%
Key Client Fiduciary Advisors, LLC 508,980$1,649,0001.36%
SILVERARC CAPITAL MANAGEMENT, LLC 1,013,664$3,284,0001.33%
ACT CAPITAL MANAGEMENT, LLC 225,000$729,0000.53%
Sio Capital Management, LLC 440,000$1,426,0000.43%
Perceptive Advisors 16,952,992$54,926,0000.42%
Artal Group S.A. 4,000,000$12,960,0000.35%
View complete list of LEAP THERAPEUTICS INC shareholders